Skip to content
  • Sunday, 26 July 2026
  • 2:08 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Johns Hopkins Researchers Discover How Gene Fusion Droplets Drive Rare Kidney Cancer Progression
Stem Cell & Regenerative Medicine

Johns Hopkins Researchers Discover How Gene Fusion Droplets Drive Rare Kidney Cancer Progression

Dwi Wanna Apr 10, 2026 0

In a landmark study published in the journal Cell Reports on April 22, investigators at the Johns Hopkins Kimmel Cancer…

Read More
Pharmaceutical R&D

FDA Proposes Permanent Authorization of Rare Pediatric Disease Priority Review Voucher Program to Foster Regulatory Stability

Teuku Ryan Apr 9, 2026 0

The United States Food and Drug Administration (FDA) is making a significant move to permanently authorize the rare pediatric disease…

Read More
Stem Cell & Regenerative Medicine

Johns Hopkins Researchers Uncover Liquid Condensate Mechanism Driving Rare Translocation Renal Cell Carcinoma and Potential Therapeutic Pathways

Dwi Wanna Apr 3, 2026 0

In a significant advancement for the field of molecular oncology, a multidisciplinary team of investigators at the Johns Hopkins Kimmel…

Read More
Pharmaceutical R&D

Biogen Acquires Apellis Pharmaceuticals for $5.6 Billion to Bolster Immunology and Rare Disease Portfolio

Teuku Ryan Apr 1, 2026 0

Biogen, a global biotechnology company renowned for its pioneering work in neuroscience, has announced a significant strategic acquisition of Apellis…

Read More
Pharmaceutical R&D

Rocket Pharmaceuticals Secures Landmark FDA Approval for Kresladi, Ushering in a New Era for Ultra-Rare Immune Disease Treatment

Teuku Ryan Mar 27, 2026 0

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Rocket Pharmaceuticals’ Kresladi (marnetegragene autotemcel), a groundbreaking gene…

Read More
Stem Cell & Regenerative Medicine

Johns Hopkins Researchers Uncover Molecular Mechanism Behind Rare Kidney Cancer Driven by Fusion Gene Liquid Droplets

Dwi Wanna Mar 26, 2026 0

In a significant advancement for the field of molecular oncology, a multidisciplinary team of investigators at the Johns Hopkins Kimmel…

Read More
Environmental & Analytical Chemistry

A Rare Lunar Impact Creates a Crater the Size of Two Football Fields

Abdurrohim Arsyad Mar 23, 2026 0

The moon, a silent sentinel in our night sky, has revealed a dramatic new feature: a fresh impact crater, estimated…

Read More
Neuroscience & Brain Research

New drug cuts seizures by up to 91% in children with rare epilepsy

Rifan Muazin Mar 22, 2026 0

In a landmark development for pediatric neurology, an international clinical trial has demonstrated that an experimental genetic therapy, zorevunersen, can…

Read More
Stem Cell & Regenerative Medicine

Johns Hopkins Researchers Uncover Molecular Mechanism Behind Rare Kidney Cancer Progression via Liquid Condensates

Dwi Wanna Mar 19, 2026 0

In a significant advancement for the field of molecular oncology, a collaborative study led by investigators at the Johns Hopkins…

Read More

Posts pagination

1 … 4 5
WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.UK Government Overhauls Medicine Regulation to Accelerate Patient Access and Boost Life Sciences SectorInnovations in AI, Data Science, and Python Architecture Dominate Mid-July 2026 DiscussionsGroundbreaking Study Reveals Psilocybin Reduces Aggression and Activity in Mangrove Rivulus Fish, Opening New Avenues for Neuropsychiatric Research
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ